These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20960822)

  • 1. [C-peptide].
    Takahashi R; Oka Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():516-8. PubMed ID: 20960822
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proinsulin, C-peptide reactive protein (CPR)].
    Takahashi R; Oka Y
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():488-92. PubMed ID: 16149558
    [No Abstract]   [Full Text] [Related]  

  • 3. Factitious and artifactual hypoglycemia.
    Horwitz DL
    Endocrinol Metab Clin North Am; 1989 Mar; 18(1):203-10. PubMed ID: 2645127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factitious hypoglycemia. Diagnosis by measurement of serum C-peptide immunoreactivity and insulin-binding antibodies.
    Scarlett JA; Mako ME; Rubenstein AH; Blix PM; Goldman J; Horwitz DL; Tager H; Jaspan JB; Stjernholm MR; Olefsky JM
    N Engl J Med; 1977 Nov; 297(19):1029-32. PubMed ID: 198659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High performance liquid chromatography used to distinguish the autoimmune hypoglycemia syndrome from factitious hypoglycemia.
    Klein RF; Seino S; Sanz N; Nolte MS; Vinik AI; Karam JH
    J Clin Endocrinol Metab; 1985 Sep; 61(3):571-4. PubMed ID: 3894407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoinsulinoma in a white man with autoimmune hypoglycemia due to anti-insulin antibodies: value of the free C-Peptide assay.
    Arzamendi AE; Rajamani U; Jialal I
    Am J Clin Pathol; 2014 Nov; 142(5):689-93. PubMed ID: 25319986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognizing factitious hypoglycemia in the family practice setting.
    Waickus CM; de Bustros A; Shakil A
    J Am Board Fam Pract; 1999; 12(2):133-6. PubMed ID: 10220236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of circulating C-peptide in diabetes mellitus and hypoglycemic disorders.
    Rubenstein AH; Kuzuya H; Horwitz DL
    Arch Intern Med; 1977 May; 137(5):625-32. PubMed ID: 193451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma C-peptide assay and the clinical significance].
    Kaku K; Nagasaka Y; Kaneko T
    Nihon Rinsho; 1990 Feb; 48 Suppl():48-50. PubMed ID: 2192142
    [No Abstract]   [Full Text] [Related]  

  • 10. C-peptide suppression test and sulphonylurea-induced factitious hypoglycaemia.
    Harrop JS; Golding PR; Goodall P; Leveau VM; Steele GA; Ingle AR
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):940-1. PubMed ID: 6802358
    [No Abstract]   [Full Text] [Related]  

  • 11. Factitious hyperinsulinemic hypoglycemia: confirmation of the diagnosis by a species-specific insulin radioimmunoassay.
    Walfish PG; Feig DS; Bauman WA
    J Endocrinol Invest; 1987 Dec; 10(6):601-4. PubMed ID: 3326893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factitious hypoglycaemia in an insulin-dependent diabetic: the value of the estimation of immunoreactive C peptide and insulin blood levels (author's transl)].
    Boyer J; Rohmer V; Davert A; Joubaud F
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2627. PubMed ID: 493062
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of insulin immunoassays in the diagnosis of factitious hypoglycemia.
    Nalbantoğlu Elmas Ö; Demir K; Soylu N; Çelik N; Özkan B
    J Clin Res Pediatr Endocrinol; 2014 Dec; 6(4):258-61. PubMed ID: 25541899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molar ratio of insulin to C-peptide. An aid to the diagnosis of hypoglycemia due to surreptitious (or inadvertent) insulin administration.
    Lebowitz MR; Blumenthal SA
    Arch Intern Med; 1993 Mar; 153(5):650-5. PubMed ID: 8439228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factitious hypoglycemia due to surreptitious administration of insulin. Diagnosis, treatment, and long-term follow-up.
    Grunberger G; Weiner JL; Silverman R; Taylor S; Gorden P
    Ann Intern Med; 1988 Feb; 108(2):252-7. PubMed ID: 3277509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoglycemia and transient diabetes mellitus in an insulin autoimmune syndrome].
    Reisch N; Zwermann O; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1135-8. PubMed ID: 15143456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide measurement: methods and clinical utility.
    Bonser AM; Garcia-Webb P
    Crit Rev Clin Lab Sci; 1984; 19(4):297-352. PubMed ID: 6373142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [C-peptide in blood].
    Matsuda A
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():35-9. PubMed ID: 9513385
    [No Abstract]   [Full Text] [Related]  

  • 19. Prime-time hypoglycemia: factitious hypoglycemia during insulin-pump therapy.
    Osipoff JN; Sattar N; Garcia M; Wilson TA
    Pediatrics; 2010 May; 125(5):e1246-8. PubMed ID: 20385648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [C-peptide (CPR)].
    Matsuda K; Oka Y
    Nihon Rinsho; 1999 Dec; 57 Suppl():313-6. PubMed ID: 10778126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.